Document Download
Firstline treatment with ruxolitinib versus best available therapy in patients with polycythemia vera: results from the randomized RuxoBEAT trial.
Author / Organization: Koschmieder S, Isfort S, Teichmann LL, Schafhausen P, Heidel FH, Crodel C, Hochhaus A, Griesshammer M, Sockel K, Jost PJ, Walther D, Döhner K, Göthert JR, Radsak M, Augustin M, Becker H, Giagounidis A, Schaich M, Klausmann M, von Bubnoff N, Stegelmann F, Kortmann M, Zentis M, Frank J, Hagemeier A, Hellmich M, Brümmendorf TH, German Study Group for Myeloproliferative Neoplasms (GSG-MPN)
| File Format | PDF (Portable Document Format) |
|---|---|
| Publication Year | 2026 |
| Source Host |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| License / Terms | Open Access / Creative Commons |
Ready for Immediate Access
Your selected document is ready for instant access with zero mandatory waiting period.
Alternative Options:
Download via MainReads Proxy
Read Online in PDF.js Viewer
Open Source Website »
Linking & Access Policy: MainReads provides direct outbound links to documents and educational resources hosted by original source repositories, universities, and open libraries. Downloads are never made conditional on advertisements or user registrations. If you encounter an inaccessible or broken resource link, please use the Report Broken Link feature on the catalog page.